SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : E*Trade (NYSE:ET)
ET 16.44+1.0%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Giambrone who wrote (2979)6/1/1998 1:33:00 AM
From: Bikergirl  Read Replies (4) of 13953
 
Any IPO that a discount brokerage company can get you shares of is not worth buying into. Investment bankers save the really hot IPO's for their brokerage arm's best clients. If there is a hot IPO, like Inktomi coming out, in which your broker has a relationship with investment banks like IPO's, you will not be able to get shares. A friend of mine has an active account at Schwab. Schwab has an IPO agreement with 3 investment banks. One is Hambrecht & Quist. HQ is helping underwrite Inktomi. Guess what? My friend asked about INKT, and Schwab is not getting any alottment through HQ. The best IPO deals are not going to go to Schwab or EGRP, although I do agree it is an added service for the clients.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext